Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome
Journal article published in 2021 by
Francesca Palandri 
,
Mario Tiribelli ,
Massimo Breccia ,
Daniela Bartoletti ,
Elena M. Elli,
Giulia Benevolo ,
Bruno Martino,
Francesco Cavazzini,
Alessia Tieghi,
Alessandra Iurlo ,
Elisabetta Abruzzese ,
Novella Pugliese ,
Gianni Binotto,
Giovanni Caocci,
Giuseppe Auteri
and other authors.
,
Mario Tiribelli ,
Massimo Breccia ,
Daniela Bartoletti ,
Elena M. Elli,
Giulia Benevolo ,
Bruno Martino,
Francesco Cavazzini,
Alessia Tieghi,
Alessandra Iurlo ,
Elisabetta Abruzzese ,
Novella Pugliese ,
Gianni Binotto,
Giovanni Caocci,
Giuseppe Auteri
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 